Amylyx Pharmaceuticals News

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Wave Life Sciences (WVE) and GoodRx Holdings (GDRX)

TipRanksMay 14 06:50 ET

Amylyx Pharma Analyst Ratings

BenzingaMay 14 06:46 ET

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)

TipRanksMay 14 06:01 ET

Bank of America Securities Keeps Their Hold Rating on Amylyx Pharmaceuticals Inc (AMLX)

TipRanksMay 13 11:06 ET

Amylyx Pharma Analyst Ratings

BenzingaMay 10 08:24 ET

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Amylyx Pharmaceuticals Inc (AMLX) and Rhythm Pharmaceuticals (RYTM)

TipRanksApr 16 05:32 ET

Hold Rating on Amylyx Pharmaceuticals Amid Uncertainties in Drug Efficacy and Market Prospects

TipRanksApr 11 08:35 ET

Amylyx Pharma Analyst Ratings

BenzingaApr 11 06:28 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Amylyx Pharmaceuticals Inc (AMLX)

TipRanksApr 11 05:23 ET

Amylyx Pharma Analyst Ratings

BenzingaApr 8 07:10 ET

Amylyx Pharmaceuticals Shifts Focus: Hold Recommendation Amidst R&D Pivot and Revenue Impact

TipRanksApr 8 04:25 ET

Deutsche Bank Cuts Amylyx Pharmaceuticals' Price Target to $4 From $8, Maintains Buy Rating

MT NewswiresApr 5 10:39 ET

Amylyx Pharmaceuticals Hold Rating: Navigating Setbacks With a Strategic Pivot and Long-Term Potential

TipRanksApr 5 04:57 ET

Amylyx Pharmaceuticals: Hold Rating Maintained Amidst Drug Discontinuation and Pipeline Developments

TipRanksApr 4 15:15 ET

Impact of Clinical Setbacks on Amylyx Pharmaceuticals: A Hold Rating Amidst Market Uncertainty

TipRanksMar 29 04:25 ET

Amylyx Pharmaceuticals: Hold Rating Maintained Amidst Development Shifts and Trial Setbacks

TipRanksMar 27 16:15 ET

Mizuho Downgrades Amylyx to Neutral After ALS Trial Setback

Seeking AlphaMar 18 09:35 ET

Maintaining Hold on Amylyx Pharmaceuticals Post-PHOENIX Study Setback and Relyvrio Uncertainties

TipRanksMar 17 15:55 ET

Amylyx Pharma Analyst Ratings

BenzingaMar 11 11:16 ET

Deutsche Bank Cuts Amylyx Pharmaceuticals' Price Target to $8 From $36, Maintains Buy Rating

MT NewswiresMar 11 10:28 ET